Author: Ojosnegros, Samuel; Beerenwinkel, Niko
Title: Models of RNA virus evolution and their roles in vaccine design Document date: 2010_11_3
ID: 0q928h3b_2
Snippet: Molecular profiling techniques, including DNA sequencing, have produced an enormous amount of data on viral spread, genetic diversity, and infection dynamics. The integration and analysis of these data can provide valuable information on the evolution of viral pathogens. Mathematical, statistical, and computational methods are necessary to deal with those large data sets and to predict phenotypes form genetic data that ultimately can be used in v.....
Document: Molecular profiling techniques, including DNA sequencing, have produced an enormous amount of data on viral spread, genetic diversity, and infection dynamics. The integration and analysis of these data can provide valuable information on the evolution of viral pathogens. Mathematical, statistical, and computational methods are necessary to deal with those large data sets and to predict phenotypes form genetic data that ultimately can be used in vaccine development. In this review, we summarize some computational and mathematical techniques that play a critical role in understanding viral evolution and vaccine design. Specifically, we discuss phylogenetic methods for vaccine strain selection, statistical models of evolutionary escape from selective immune pressure, and virus dynamics models for therapeutic vaccines and attenuation strategies. Our major examples are Influenza, human immunodeficiency virus (HIV), and foot-and-mouth disease virus (FMDV). They are all RNA viruses of great medical or veterinary importance and have been studied extensively.
Search related documents:
Co phrase search for related documents- statistical model and valuable information: 1, 2, 3, 4
- statistical model and valuable information provide: 1, 2, 3
- statistical model and viral evolution: 1
- statistical model and viral spread: 1
- therapeutic vaccine and ultimately vaccine development: 1
- therapeutic vaccine and vaccine design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63
- therapeutic vaccine and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- therapeutic vaccine and valuable information: 1, 2, 3, 4, 5, 6, 7, 8, 9
- therapeutic vaccine and valuable information provide: 1, 2
- therapeutic vaccine and viral evolution: 1, 2, 3, 4, 5, 6, 7, 8
- therapeutic vaccine and viral pathogen: 1, 2, 3
- therapeutic vaccine and viral spread: 1, 2
- therapeutic vaccine and virus dynamic: 1
- ultimately vaccine development and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8
- ultimately vaccine development and viral spread: 1
- vaccine design and valuable information: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- vaccine design and valuable information provide: 1, 2, 3, 4
- vaccine design and viral evolution: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- vaccine design and viral pathogen: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date